Burning Rock Biotech (BNR) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$65.6 million.
- Burning Rock Biotech's Enterprise Value rose 761.13% to -$65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.6 million, marking a year-over-year increase of 761.13%. This contributed to the annual value of -$71.5 million for FY2024, which is 1745.97% up from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's Enterprise Value is -$65.6 million, which was up 761.13% from -$63.5 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Enterprise Value ranged from a high of -$63.5 million in Q2 2025 and a low of -$322.5 million during Q1 2021
- For the 5-year period, Burning Rock Biotech's Enterprise Value averaged around -$137.1 million, with its median value being -$101.1 million (2023).
- As far as peak fluctuations go, Burning Rock Biotech's Enterprise Value tumbled by 1208714.14% in 2021, and later soared by 4409.27% in 2022.
- Burning Rock Biotech's Enterprise Value (Quarter) stood at -$195.9 million in 2021, then soared by 31.5% to -$134.2 million in 2022, then soared by 35.41% to -$86.7 million in 2023, then increased by 17.44% to -$71.5 million in 2024, then increased by 8.3% to -$65.6 million in 2025.
- Its Enterprise Value stands at -$65.6 million for Q3 2025, versus -$63.5 million for Q2 2025 and -$68.5 million for Q1 2025.